06/12/2025
3:30 PM | Design Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:30 PM | Design Therapeutics (Issuer)
Schmid John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:30 PM | Berger Heather A. (Reporting)
Design Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:30 PM | Design Therapeutics (Issuer)
William Arsani (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:30 PM | Design Therapeutics (Issuer)
Prasad Deepa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2025
11:15 PM | Design Therapeutics (Filer)
| Form EFFECT | |
04/24/2025
3:13 PM | Design Therapeutics (Filer)
| Form ARS | |
03/10/2025
6:30 AM | Design Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/10/2025
6:10 AM | Design Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/10/2025
6:16 AM | Design Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/13/2025
8:09 AM | Design Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
6:00 PM | Design Therapeutics (Issuer)
Jeffries Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:00 PM | Design Therapeutics (Issuer)
Shah Pratik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:00 PM | Burgess Julie (Reporting)
Design Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:00 PM | Design Therapeutics (Issuer)
LAPPE RODNEY W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
5:30 PM | Design Therapeutics (Issuer)
Prasad Deepa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
5:53 PM | Design Therapeutics (Subject)
Logos Global Management LP (Filed by)
| Form SC 13D/A | |
08/12/2024
3:30 PM | Design Therapeutics (Issuer)
William Arsani (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
3:20 PM | Design Therapeutics (Subject)
Logos SPV 1 LP (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
7:01 AM | Design Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
7:12 AM | Design Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Free DSGN Stock Alerts